Apart from software, the technique needs nothing more than a halogen lamp and a commercial-grade spectrometer. This pairing can be had together for well under $5,000.

The FDA has given the all-clear to AI software that measures nodules in the lungs, a tedious but important task for radiologists monitoring changes in these growths over time.

An AI system for diagnosing prostate cancer on biopsy slides has achieved 98%-plus performance in sensitivity, positive predictive value, specificity and negative predictive value.

Two healthcare heavyweights are combining forces to form a technology center they hope will, over the next 10 years, “fundamentally advance the pace” of discovery in medical science and healthcare innovation.

Last week a literature review showed none of 62 high-quality medical AI models ready for translation from academic research to clinical practice. Now comes a similar but separate study confirming the depth of the dashed hopes.

The FDA has granted 510(k) clearance to clinical decision support software that uses AI to detect small but potentially cancerous lesions in the lungs.

The FDA has blessed an AI-packing armband that checks for biometric patterns pointing to possible SARS-CoV-2 infection in individuals with no symptoms.

The European Union has granted CE mark approval to a U.S.-based maker of AI software that aids radiologists in distinguishing between benign and malignant lesions on breast ultrasound images.